Controversy expected over US FDA commissioner posting
This article was originally published in Clinica
Executive Summary
Speculation is mounting in Washington about whether President Bush will defy leading Senate Democrats and appoint an FDA commissioner with ties to industry. Earlier this month, Senator Edward Kennedy sent a letter to Mr Bush urging him to act quickly to name a commissioner, but warned the President against taking the unprecedented step of choosing someone from an industry regulated by the FDA.